News › Clinical Practice, Industry News, Patient Care

Non-Melanoma Treatment Markets Heat Up

November 27, 2017

Melanoma is not the only skin cancer—other diseases such as squamous and basal cell carcinoma are dangerous in their own right, and are on the rise. According to new research from Persistence Market Research, the treatment markets for non-melanoma skin cancer treatments are expanding—analysts expect the overall market to exceed $4.7 billion by the end of 2025.
The most common type of skin cancer, basal cell carcinoma can be recognized by dome-shaped skin growths, shiny pink or red patches, or waxy pale growths that resemble a scar. Squamous cell carcinoma, on the other hand, is likely to present as sores that heal and return, do not heal at all, flat red patches or rough-feeling bumps on the skin.
Read more at Skin Inc >>  

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Retatrutide Phase 3 Trial: Adults With Type 2 Diabetes Lost Average of 50 Pounds
    • Medical Marketing Whiz Recognized With Healthcare Digital Marketing Excellence Award
    • Allergan Presents Early Data on Skin Quality Treatments for Patients Taking Weight-Loss Medications
    • ValueCap Becomes Silver Vendor Affiliate with the American Med Spa Association
    • FDA Warning Letter Signals Increased Scrutiny of the Medical Necessity Exception for Compounded GLP-1s
Advertisement